• Privacy Policy
  • Terms Of Service
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
Forex trading, free forex education | Forex.ca

 

  • Home
  • Forex News
  • Stock News
  • For Beginners
  • Market Analysis
  • Trading Strategies
  • Real Time Stock Update
  • Shop
News Ticker
  • [ September 30, 2025 ] Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders Stock News
  • [ September 30, 2025 ] Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary Stock News
  • [ September 30, 2025 ] Tesla (TSLA) Share Price Rises Ahead of Earnings Report Forex News
  • [ September 29, 2025 ] Accenture: The Best Way To Play AI's Next Phase Stock News
  • [ September 29, 2025 ] Growth & Total Return Weekly Chat Stock News
Home2022July

Month: July 2022

No Picture
Stock News

Weyerhaeuser Company (WY) CEO Devin Stockfish on Q2 2022 Results – Earnings Call Transcript

July 29, 2022 admin 0

Weyerhaeuser Company (NYSE:WY) Q2 2022 Results Conference Call July 29, 2022 10:00 AM ET Company Participants Andy Taylor – Director of Investor Relations Devin Stockfish – Chief Executive Officer David Wold – Chief Financial Officer […]

Stock News

NXP Semiconductors: Remarkable Rally From July Lows, Don’t Add Now

July 29, 2022 admin 0

FinkAvenue/iStock Editorial via Getty Images Thesis NXP Semiconductors’ (NASDAQ:NXPI) FQ2 earnings card demonstrated the strength of its diversified and robust portfolio, leveraging the growth cadence of its automotive and industrial segments. Management continues to see […]

Stock News

Amphenol Stock: Compounding At Work (NYSE:APH)

July 29, 2022 admin 0

feellife/iStock via Getty Images Shares of Amphenol (NYSE:APH) have come to life in recent sessions as the business has continued to grow along and pursue bolt-on dealmaking. This is sufficient of a reason to update […]

Posts navigation

« 1 … 157 158 159 … 2,356 »

For Beginners


Categories

  • Forex News
  • Stock News
No Picture
Stock News

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

September 30, 2025 0

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

Stock News

Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary

September 30, 2025 0

Follow Summary The second quarter of 2025 was defined by several key policies from the new Trump administration, including tariffs/trade, immigration, and taxes. The fund returned 1.88% in the second quarter versus the ICE BoA […]

Latest news
  • Tesla (TSLA) Share Price Rises Ahead of Earnings Report
    September 30, 2025 0
  • Nikkei 225 Rises Following Resignation of Prime Minister Shigeru Ishiba
    September 8, 2025 0
Random News
  • Stocks Rocked on Rates Ahead of the Fed
    January 21, 2022 0
  • Pay off Student Loans or Invest—Which is Best?
    April 11, 2022 0
  • Southwest Airlines predicts solid annual profit as travel rebounds By Reuters
    April 28, 2022 0
Email Inquiries to: warp1@sympatico.ca
  • No Picture
    Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders
    September 30, 2025 0
  • Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary
    September 30, 2025 0
Pages
  • Contact Us
  • Home
  • Privacy Policy
  • Real Time Stock Update
  • Shop
  • Terms Of Service

© Copyright 2020-2023 Forex.ca

Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.